Mark W. Rolfe

3.1k total citations · 1 hit paper
45 papers, 2.7k citations indexed

About

Mark W. Rolfe is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Mark W. Rolfe has authored 45 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in Mark W. Rolfe's work include Transplantation: Methods and Outcomes (8 papers), Immune Response and Inflammation (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). Mark W. Rolfe is often cited by papers focused on Transplantation: Methods and Outcomes (8 papers), Immune Response and Inflammation (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). Mark W. Rolfe collaborates with scholars based in United States, United Kingdom and Australia. Mark W. Rolfe's co-authors include Robert M. Strieter, Steven L. Kunkel, Rodney Rothstein, Gary Chrebet, John W. Wallis, Gary Brodsky, T J Standiford, Marie D. Burdick, Theodore J. Standiford and Robert M. Strieter and has published in prestigious journals such as Nature, Cell and The Journal of Experimental Medicine.

In The Last Decade

Mark W. Rolfe

45 papers receiving 2.6k citations

Hit Papers

A hyper-recombination mutation in S. cerevisiae identifie... 1989 2026 2001 2013 1989 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A hyper-recombination mutation in S. cerevisiae identifies a novel eukaryotic topoisomerase
    1989 484 citations John W. Wallis, Gary Chrebet et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark W. Rolfe United States 26 1.0k 762 593 346 343 45 2.7k
Atsushi Komatsuda Japan 30 1.3k 1.3× 483 0.6× 588 1.0× 248 0.7× 272 0.8× 193 3.5k
Shuen‐Kuei Liao Taiwan 28 788 0.8× 386 0.5× 752 1.3× 408 1.2× 302 0.9× 117 2.3k
Atsuhisa Ueda Japan 28 1.1k 1.0× 323 0.4× 560 0.9× 327 0.9× 269 0.8× 90 2.6k
A. Brent Carter United States 21 1.8k 1.7× 667 0.9× 1.4k 2.4× 239 0.7× 431 1.3× 26 3.3k
Taylor P. Sherrill United States 26 823 0.8× 1.1k 1.5× 959 1.6× 455 1.3× 354 1.0× 48 2.8k
Scott K. Young United States 23 738 0.7× 556 0.7× 1.2k 2.1× 362 1.0× 280 0.8× 31 2.4k
Christian Vesin Switzerland 30 546 0.5× 808 1.1× 1.0k 1.7× 291 0.8× 269 0.8× 50 3.0k
Keiji Yoshinaga Japan 24 1.5k 1.5× 376 0.5× 610 1.0× 520 1.5× 200 0.6× 49 2.9k
M A Gougerot-Pocidalo France 19 407 0.4× 427 0.6× 708 1.2× 148 0.4× 484 1.4× 30 1.9k
Susumu Miyata Japan 20 890 0.9× 187 0.2× 431 0.7× 245 0.7× 196 0.6× 29 2.2k

Countries citing papers authored by Mark W. Rolfe

Since Specialization
Citations

This map shows the geographic impact of Mark W. Rolfe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Rolfe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Rolfe more than expected).

Fields of papers citing papers by Mark W. Rolfe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Rolfe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Rolfe. The network helps show where Mark W. Rolfe may publish in the future.

Co-authorship network of co-authors of Mark W. Rolfe

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Rolfe. A scholar is included among the top collaborators of Mark W. Rolfe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Rolfe. Mark W. Rolfe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Decker, Summer, et al.. (2016). Middle Lobe Torsion after Unilateral Lung Transplant. Journal of Radiology Case Reports. 10(5). 15–21. 8 indexed citations
2.
Trapnell, Bruce C., Susanna A. McColley, Dana G. Kissner, et al.. (2011). Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis with Pseudomonas Airway Infection. American Journal of Respiratory and Critical Care Medicine. 185(2). 171–178. 103 indexed citations
3.
Zamora, Martin R., Marie Budev, Mark W. Rolfe, et al.. (2010). RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus. American Journal of Respiratory and Critical Care Medicine. 183(4). 531–538. 169 indexed citations
4.
Weston, Mark, Mark W. Rolfe, Tarik Haddad, & Mayra Lopez‐Cepero. (2009). Desensitization protocol using bortezomib for highly sensitized patients awaiting heart or lung transplants.. PubMed. 393–9. 16 indexed citations
5.
6.
Rumbak, Mark J., et al.. (1999). Significant Tracheal Obstruction Causing Failure to Wean in Patients Requiring Prolonged Mechanical Ventilation. CHEST Journal. 115(4). 1092–1095. 63 indexed citations
7.
8.
James, Neil H., Jason H. Gill, Richard Brindle, et al.. (1998). Peroxisome proliferator-activated receptor (PPAR) alpha-regulated growth responses and their importance to hepatocarcinogenesis. Toxicology Letters. 102-103. 91–96. 23 indexed citations
9.
Smith, Daniel R., Steven L. Kunkel, T J Standiford, et al.. (1995). Increased Interleukin-1 Receptor Antagonist in Idiopathic Pulmonary Fibrosis. A Compartmental Analysis. American Journal of Respiratory and Critical Care Medicine. 151(6). 1965–1973. 32 indexed citations
10.
Suitters, Amanda, Roly Foulkes, Steven M. Opal, et al.. (1994). Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock.. The Journal of Experimental Medicine. 179(3). 849–856. 52 indexed citations
11.
Cornblath, Wayne T., Victor M. Elner, & Mark W. Rolfe. (1993). Extraocular Muscle Involvement in Sarcoldosis. Ophthalmology. 100(4). 501–505. 24 indexed citations
12.
Rolfe, Mark W., Steven L. Kunkel, Pamela M. Lincoln, et al.. (1993). Lung Allograft Rejection: Role of Tumor Necrosis Factor-Alpha and lnterleukin-6. CHEST Journal. 103(2). 133S–133S. 14 indexed citations
13.
Rolfe, Mark W., T J Standiford, Steven L. Kunkel, et al.. (1993). Interleukin-1 Receptor Antagonist Expression in Sarcoidosis. American Review of Respiratory Disease. 148(5). 1378–1384. 22 indexed citations
14.
Standiford, Theodore J., Steven L. Kunkel, Mark W. Rolfe, et al.. (1992). Regulation of Human Alveolar Macrophage- and Blood Monocyte-derived Interleukin-8 by Prostaglandin E2 and Dexamethasone. American Journal of Respiratory Cell and Molecular Biology. 6(1). 75–81. 103 indexed citations
15.
Moore, Susan A., Robert M. Strieter, Mark W. Rolfe, et al.. (1992). Expression and Regulation of Human Alveolar Macrophage-derived Interleukin-1 Receptor Antagonist. American Journal of Respiratory Cell and Molecular Biology. 6(6). 569–575. 41 indexed citations
16.
Rolfe, Mark W., Steven L. Kunkel, Theodore J. Standiford, et al.. (1991). Pulmonary Fibroblast Expression of Interleukin-8: A Model for Alveolar Macrophage-derived Cytokine Networking. American Journal of Respiratory Cell and Molecular Biology. 5(5). 493–501. 127 indexed citations
17.
Standiford, Theodore J., et al.. (1991). Interleukin-8 Gene Expression from Human Alveolar Macrophages: The Role of Adherence. American Journal of Respiratory Cell and Molecular Biology. 5(6). 579–585. 62 indexed citations
18.
Ham, J. M., et al.. (1991). Chemotactic Cytokine (IL-8 and MCP-1) Gene Expression by Human Whole Blood. Immunological Investigations. 20(4). 387–394. 15 indexed citations
19.
Wallis, John W., Gary Chrebet, Gary Brodsky, Mark W. Rolfe, & Rodney Rothstein. (1989). A hyper-recombination mutation in S. cerevisiae identifies a novel eukaryotic topoisomerase. Cell. 58(2). 409–419. 484 indexed citations breakdown →
20.
Rolfe, Mark W.. (1985). UV-inducible transcripts in Saccharomyces cerevisiae. Current Genetics. 9(7). 533–538. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atsushi Komatsuda Breakdown of academic impact, for papers by Shuen‐Kuei Liao Breakdown of academic impact, for papers by Atsuhisa Ueda Breakdown of academic impact, for papers by A. Brent Carter Breakdown of academic impact, for papers by Taylor P. Sherrill Breakdown of academic impact, for papers by Scott K. Young Breakdown of academic impact, for papers by Christian Vesin Breakdown of academic impact, for papers by Keiji Yoshinaga Breakdown of academic impact, for papers by M A Gougerot-Pocidalo Breakdown of academic impact, for papers by Susumu Miyata
Rankless by CCL
2026